GELS

Peers: AQST LFCR YCBD ETON RDHL SNOA CPIX SBFM PAHC LFVN

Index	-
Market Cap	4.71M
Enterprise Value	-
Income	-4.57M
Sales	0.11M
Book/sh	0.85
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Oct 29, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	42.84
P/B	0.52
P/C	471.21
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	0.09
Debt/Eq	0.36
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-0.45
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-18.35% -
Sales past 3/5Y	0.08% -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	0.98%
Inst Trans	5.98%
ROA	-31.56%
ROE	-43.32%
ROIC	-48.23%
Gross Margin	-869.36%
Oper. Margin	-4107.16%
Profit Margin	-4350.49%
SMA20	-13.23%
SMA50	-23.67%
SMA200	-34.78%
Trades

Shs Outstand	9.44M
Shs Float	5.62M
Short Float	9.27%
Short Ratio	0.18
Short Interest	0.52M
52W High	2.01 -78.12%
52W Low	0.39 13.64%
Volatility	7.52% 13.35%
ATR (14)	0.06
RSI (14)	37.26
Beta	-0.37
Rel Volume	0.00
Avg Volume	2.82M
Volume	7,183

Perf Week	-2.31%
Perf Month	-27.90%
Perf Quarter	-40.81%
Perf Half Y	-39.81%
Perf YTD	-45.03%
Perf Year	-64.82%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	0.45
Price	0.44
Change %	-1.83%

Jun-17-26 08:30AM	Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs (GlobeNewswire) -7.32%
Jun-12-26 12:30PM	Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq Technology for Animal Health Applications (GlobeNewswire) -35.29%
Jun-04-26 09:08AM	Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion (GlobeNewswire) +5.78%
May-20-26 08:00AM	Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway (GlobeNewswire) +16.66%
May-14-26 08:35AM	Healthy Extracts Q1 2026 Net Revenue Up 73% to Record $1.6 Million, Driving Positive EBITDA (ACCESSWIRE)
08:00AM	Loading…
May-12-26 08:00AM	Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth (GlobeNewswire)
Apr-02-26 06:55AM	Healthy Extracts Reports Preliminary 2025 Results, Net Revenue Expected Up 45% to Record $4.5 Million (ACCESSWIRE) -8.04%
Feb-11-26 08:45AM	Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership (GlobeNewswire)
Jan-14-26 09:16AM	Gelteq announces preclinical results on medicinal cannabinoid absorption (TipRanks) +39.24%
05:03AM	Stock Market Today: Dow Jones, Nasdaq 100 Futures Tumble Ahead Of Supreme Court Ruling On Trump's Tariffs-Wells Fargo, BP, WeRide In Focus (Benzinga)
Jan-13-26 11:01PM	What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge? (Benzinga) +6.44%
09:00AM	Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform (GlobeNewswire)
Dec-16-25 09:05AM	Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program (GlobeNewswire)
Dec-09-25 09:15AM	Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq's Nutritional Product Expansion into China (GlobeNewswire)
Dec-05-25 10:30AM	Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform (GlobeNewswire)
08:30AM	Loading…
Dec-02-25 08:30AM	Gelteq to Present at Investor Summit Virtual on December 9, 2025 (GlobeNewswire)
Nov-24-25 08:30AM	Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform (GlobeNewswire) +20.39%
Oct-23-25 09:00AM	Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform (GlobeNewswire) +23.01%
Oct-09-25 08:00AM	Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound (GlobeNewswire) +6.25%
Sep-12-25 07:30AM	Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner (GlobeNewswire) +6.67%
Sep-05-25 11:26AM	Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market (GlobeNewswire) +62.50%
10:30AM	BC-Most Active Stocks (Associated Press Finance)
Sep-04-25 08:35AM	Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs (ACCESSWIRE) -14.29%
Jul-17-25 08:30AM	Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities (GlobeNewswire) +10.00%
Jun-10-25 07:30AM	Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner (GlobeNewswire) +73.53%
May-03-25 11:00AM	Ford, Disney, And AMD To Report Results Next Week (Seeking Alpha)
Feb-27-25 08:45AM	Gelteq's Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand (GlobeNewswire)
Feb-04-25 08:00AM	Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC (GlobeNewswire)
Jan-24-25 08:00AM	Gelteq Appoints Matthew Jones as Head of Sports Performance (GlobeNewswire)
Dec-19-24 08:30AM	Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology (GlobeNewswire) +21.97%
08:30AM	Loading…
Dec-17-24 08:30AM	Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug (GlobeNewswire) +5.79%
Dec-09-24 08:30AM	Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference (GlobeNewswire) +78.00%
Dec-02-24 08:30AM	Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand (GlobeNewswire) +91.02%
Nov-26-24 08:30AM	Gelteq Announces 400,000 Units Enter into Production in November 2024 (GlobeNewswire)
Nov-12-24 09:00AM	Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business (GlobeNewswire)
Oct-30-24 10:00AM	Gelteq Limited Closes US$5.2 Million Initial Public Offering (GlobeNewswire) -19.40%
Oct-28-24 09:50PM	Gelteq Limited Prices US$5.2 Million Initial Public Offering (GlobeNewswire)

Show Previous News

Gelteq Ltd. operates as a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.

Co-FounderMr. Nathan Jacob Givoni

Co-Founder & Non-Executive ChairmanMr. Simon Hayden Szewach

Chief Financial OfficerMs. Thuy-Linh Gigler

Chief Scientific OfficerDr. Paul M. Wynne Ph.D.

Head of Sales & MarketingBradley Glenn Karp

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Gelteq Ltd

Upgrade your Finviz experience